Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interruption of the Calcineurine Inhibitors (ICN) and Introduction of Mycophenolate Mofetil (MMF) in Liver Transplant Patients With Side Effects Due to ICN: Study of the Reduction of the Risks of Rejection by Mycophenolate Mofetil Therapeutic Drug Monitoring

NCT00456235 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT00456235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00456235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interruption of the Calcineurine Inhibitors (ICN) and Introduction of Mycophenolate Mofetil (MMF) in Liver Transplant Patients With Side Effects Due to ICN: Study of the Reduction of the Risks of Rejection by Mycophenolate Mofetil Therapeutic Drug Monitoring
Lead sponsor
University Hospital, Limoges
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2011
Enrollment
92 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation